1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 年齢層別スニペット
3.3. 適応症別スニペット
3.4. エンドユーザー別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. ビリルビン測定器の技術進歩
4.1.2. 阻害要因
4.1.2.1. 装置の高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. 償還分析
5.6. 特許分析
5.7. SWOT分析
5.8. DMI意見
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. ベンチトップ
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. 経皮
7. 年齢層別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, 年齢層別
7.1.2. 市場魅力度指数（年齢層別
7.2. 新生児*市場
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 大人
7.4. その他
8. 適応症別
8.1. 導入剤
8.1.1. 市場規模分析および前年比成長率分析（％）、適応症別
8.1.2. 市場魅力度指数、適応症別
8.2. 肝炎*市場
8.2.1. 序論
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 黄疸
8.4. その他
9. エンドユーザー別
9.1. はじめに
9.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
9.1.2. 市場魅力度指数、エンドユーザー別
9.2. 病院*市場
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. クリニック
9.4. 診断センター
9.5. その他
10. 地域別
10.1. はじめに
10.1.1. 地域別市場規模分析および前年比成長率分析(%)
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. 序論
10.2.2. 地域別主要市場
10.2.2.1. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.2.2.2. 市場規模分析および前年比成長率分析（%）、年齢層別
10.2.2.3. 市場規模分析および前年比成長率分析（%）、適応症別
10.2.2.4. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.2.3. 市場規模分析および前年比成長率分析（%）, 国別
10.2.3.1. 米国
10.2.3.2. カナダ
10.2.3.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 地域別主要市場
10.3.2.1. 市場規模分析および前年比成長率分析(%)、製品タイプ別
10.3.2.2. 市場規模分析および前年比成長率分析（%）：年齢層別
10.3.2.3. 市場規模分析および前年比成長率分析（%）、適応症別
10.3.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.3.4. 市場規模分析および前年比成長率分析（%）, 国別
10.3.4.1. ドイツ
10.3.4.2. イギリス
10.3.4.3. フランス
10.3.4.4. イタリア
10.3.4.5. スペイン
10.3.4.6. その他のヨーロッパ
10.4. 南米
10.4.1. はじめに
10.4.2. 地域別主要市場
10.4.2.1. 市場規模分析および前年比成長率分析(%)、製品タイプ別
10.4.2.2. 市場規模分析および前年比成長率分析（%）：年齢層別
10.4.2.3. 市場規模分析および前年比成長率分析（%）：適応症別
10.4.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.4.4. 市場規模分析および前年比成長率分析（%）, 国別
10.4.4.1. ブラジル
10.4.4.2. アルゼンチン
10.4.4.3. その他の南米諸国
10.5. アジア太平洋
10.5.1. 序論
10.5.2. 主な地域別ダイナミクス
10.5.2.1. 市場規模分析および前年比成長率分析(%)、製品タイプ別
10.5.2.2. 市場規模分析および前年比成長率分析（%）、年齢層別
10.5.2.3. 市場規模分析および前年比成長率分析（%）、適応症別
10.5.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.5.4. 市場規模分析および前年比成長率分析（%）, 国別
10.5.4.1. 中国
10.5.4.2. インド
10.5.4.3. 日本
10.5.4.4. 韓国
10.5.4.5. その他のアジア太平洋地域
10.6. 中東・アフリカ
10.6.1. 序論
10.6.2. 地域別主要市場
10.6.2.1. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.6.2.2. 市場規模分析および前年比成長率分析（%）、年齢層別
10.6.2.3. 市場規模分析および前年比成長率分析（%）、適応症別
10.6.3. 市場規模分析および前年比成長率分析（%）：エンドユーザー別
11. 競合情勢
11.1. 競争シナリオ
11.2. 市場ポジショニング／シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. Delta Medical International Ltd*
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. Mennen Medical Ltd
12.3. Ningbo David Medical Device Co. Ltd.
12.4. Micro Lab Instruments
12.5. Zeal Medical
12.6. Drägerwerk AG & Co. KGaA
12.7. Labtron Equipment Ltd
12.8. Korrida Medical Systems
12.9. GPC Medical Ltd
12.10. Braun & Co. Limited
リストは網羅的ではありません
13. 付録
13.1. 当社とサービスについて
13.2. お問い合わせ

Overview
Global Bilirubin Meters Market reached US$ 108.1 million in 2023 and is expected to reach US$ 136.4 million by 2031, growing at a CAGR of 10.16% during the forecast period 2024-2031.

The bilirubin meter is a device that measures the amount of bilirubin in a patient's blood. It is an important tool in the diagnosis and treatment of neonatal jaundice. It typically uses spectrophotometric methods to measure bilirubin levels, which aids in the diagnosis and monitoring of illnesses like jaundice, liver disease, and hemolytic disorders.
Bilirubin meters can be found in both portable and laboratory settings, giving essential data for clinical decision-making. Commonly used in neonates to assess jaundice, determining its severity and the need for treatment, such as phototherapy. They help in evaluating and analyzing bilirubin metabolism and help in diagnosing liver diseases such as hepatitis, cirrhosis, and other metabolic diseases.

Market Dynamics: Drivers & Restraints
Technological advancement in bilirubin meters
Technological advancements in bilirubin meters are expected to drive the market growth. Enhanced measuring techniques, such as enhanced spectrophotometry and multi-wavelength analysis, produce more consistent results, boosting trust in these instruments. Non-invasive bilirubin meters, that utilize light sensors to monitor bilirubin levels via the skin are expected to improve the comfort and accessibility of screening, especially for babies.
Advances in miniaturization and user interface design have led to more portable, simple-to-use devices that can be operated by healthcare professionals with minimal instruction, allowing for widespread use. Faster analysis times improve workflow efficiency in clinical environments, allowing for rapid diagnostic and treatment decisions. Technological advancements can result in lower manufacturing costs, making bilirubin meters cheaper for healthcare facilities and boosting market share. Thus, the above factors are expected to drive the market growth.

High cost of the devices
Hospitals and clinics, particularly in low- and middle-income areas, may need help with funding costly equipment. This can limit their ability to invest in new technologies, impeding their adoption. If cheaper options exist, buyers in the future may choose them, making it difficult for high-priced products to compete. This could result in a lower market share for premium products.

Segment Analysis
The global bilirubin meters market is segmented based on product type, age group, indication, end-user, and region.
Transcutaneous segment is expected to dominate the market share
The transcutaneous segment holds a significant position in the global market share and is expected to continue throughout the forecast period. These gadgets are non-invasive, accurate, cost-effective, and time-saving.
Moreover, transcutaneous devices are used to screen jaundice in newborn babies without a needle prick, and they are becoming more popular as an alternative to serum bilirubin analyzers. Transcutaneous bilirubinometers serve as a valid screening method for identifying neonates who require total serum bilirubin measurement before phototherapy.
Transcutaneous meters produce immediate results, allowing for more rapid clinical decision-making and rapid action in situations like as jaundice. Due to their efficiency and portability, these devices are gaining demand and are expected to hold a significant position in the market share.

Geographical Analysis
North America is expected to hold a significant position in the bilirubin meters market share
North America accounted for the highest revenue share. The increasing prevalence of liver diseases, the rising geriatric population, rising healthcare spending, well-established infrastructure, and technological advancements in bilirubin meters are factors expected to boost the market in the forecast period.
For instance, according to the Children's Hospital of Philadelphia in 2024, it is stated that hyperbilirubinemia is very common, affecting approximately 60 percent of term newborns and 80 percent of premature babies develop jaundice. The increasing number of hyperbilirubinemias requires continuous evaluation and analysis of the quantity of bilirubin, thus increasing the demand for the devices. Thus, the above factors are expected to hold the region’s market growth.

Market Segmentation
By Product Type
• Bench-top
• Transcutaneous
By Age Group
• Neonates
• Adults
• Others
By Indication
• Hepatitis
• Jaundice
• Others
By End-User
• Hospitals
• Clinics
• Diagnostic Centers
• Others
By Region
• North America
o The U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape
The major global players in the market include Delta Medical International Ltd, Mennen Medical Ltd, Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zeal Medical, Drägerwerk AG & Co. KGaA, Labtron Equipment Ltd, Korrida Medical Systems, GPC Medical Ltd and Braun & Co. Limited. among others.

Why Purchase the Report?
• To visualize the global bilirubin meters
Market Segmentation based on product type, age group, indication, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of bilirubin meters market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global bilirubin meters market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Age Group
3.3. Snippet by Indication
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancement in bilirubin meters
4.1.2. Restraints
4.1.2.1. High cost of the devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Bench-top*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Transcutaneous
7. By Age Group
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
7.1.2. Market Attractiveness Index, By Age Group
7.2. Neonates*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Adults
7.4. Others
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.1.2. Market Attractiveness Index, By Indication
8.2. Hepatitis*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Jaundice
8.4. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Diagnostic Centers
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.3.1. The U.S.
10.2.3.2. Canada
10.2.3.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.4.1. Germany
10.3.4.2. UK
10.3.4.3. France
10.3.4.4. Italy
10.3.4.5. Spain
10.3.4.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.4.1. Brazil
10.4.4.2. Argentina
10.4.4.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.4.1. China
10.5.4.2. India
10.5.4.3. Japan
10.5.4.4. South Korea
10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Delta Medical International Ltd*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Mennen Medical Ltd
12.3. Ningbo David Medical Device Co. Ltd.
12.4. Micro Lab Instruments
12.5. Zeal Medical
12.6. Drägerwerk AG & Co. KGaA
12.7. Labtron Equipment Ltd
12.8. Korrida Medical Systems
12.9. GPC Medical Ltd
12.10. Braun & Co. Limited
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

❖ 世界のビリルビンメーター市場に関するよくある質問(FAQ) ❖

・ビリルビンメーターの世界市場規模は？
→DataM Intelligence社は2023年のビリルビンメーターの世界市場規模を1億810万米ドルと推定しています。

・ビリルビンメーターの世界市場予測は？
→DataM Intelligence社は2031年のビリルビンメーターの世界市場規模を1億3,640万米ドルと予測しています。

・ビリルビンメーター市場の成長率は？
→DataM Intelligence社はビリルビンメーターの世界市場が2024年～2031年に年平均10.2%成長すると予測しています。

・世界のビリルビンメーター市場における主要企業は？
→DataM Intelligence社は「Delta Medical International Ltd、Mennen Medical Ltd、Ningbo David Medical Device Co. Ltd.、Micro Lab Instruments、Zeal Medical、Drägerwerk AG & Co. KGaA、Labtron Equipment Ltd、Korrida Medical Systems、GPC Medical Ltd、Braun & Co. Limitedなど ...」をグローバルビリルビンメーター市場の主要企業として認識しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。